185 related articles for article (PubMed ID: 35952694)
21. Remission with Imatinib mesylate treatment in a patient with initially unresectable dermatofibrosarcoma protuberans--a case report.
Lemm D; Muegge LO; Hoeffken K; Aklan T; Mentzel T; Thorwarth M; Schultze-Mosgau S
Oral Maxillofac Surg; 2008 Dec; 12(4):209-13. PubMed ID: 18751744
[TBL] [Abstract][Full Text] [Related]
22. Dermatofibrosarcoma protuberans: recent clinical progress.
McArthur G
Ann Surg Oncol; 2007 Oct; 14(10):2876-86. PubMed ID: 17647063
[TBL] [Abstract][Full Text] [Related]
23. Current treatment options in dermatofibrosarcoma protuberans.
Lemm D; Mügge LO; Mentzel T; Höffken K
J Cancer Res Clin Oncol; 2009 May; 135(5):653-65. PubMed ID: 19205737
[TBL] [Abstract][Full Text] [Related]
24. Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
Kambayashi Y; Kasahara Y; Ohuchi K; Amagai R; Hashimoto A; Asano Y; Fujimura T
Dermatol Ther; 2022 Oct; 35(10):e15736. PubMed ID: 35898161
[TBL] [Abstract][Full Text] [Related]
25. Molecular targeting of dermatofibrosarcoma protuberans: a new approach to a surgical disease.
McArthur GA
J Natl Compr Canc Netw; 2007 May; 5(5):557-62. PubMed ID: 17509258
[TBL] [Abstract][Full Text] [Related]
26. S1 guidelines for dermatofibrosarcoma protuberans (DFSP) - update 2018.
Ugurel S; Kortmann RD; Mohr P; Mentzel T; Garbe C; Breuninger H; Bauer S; Grabbe S
J Dtsch Dermatol Ges; 2019 Jun; 17(6):663-668. PubMed ID: 31115967
[TBL] [Abstract][Full Text] [Related]
27. Current Update on the Molecular Biology of Cutaneous Sarcoma: Dermatofibrosarcoma Protuberans.
Iwasaki T; Yamamoto H; Oda Y
Curr Treat Options Oncol; 2019 Mar; 20(4):29. PubMed ID: 30874910
[TBL] [Abstract][Full Text] [Related]
28. PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans.
Cloutier JM; Allard G; Bean GR; Hornick JL; Charville GW
Mod Pathol; 2021 Aug; 34(8):1521-1529. PubMed ID: 33762682
[TBL] [Abstract][Full Text] [Related]
29. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review.
Banach BS; Antic T; Bridge JA; Cipriani NA; Frye L; Krausz TN; Biernacka A
Diagn Cytopathol; 2019 Aug; 47(8):797-802. PubMed ID: 30919592
[TBL] [Abstract][Full Text] [Related]
30. Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency.
Kesserwan C; Sokolic R; Cowen EW; Garabedian E; Heselmeyer-Haddad K; Lee CC; Pittaluga S; Ortiz C; Baird K; Lopez-Terrada D; Bridge J; Wayne AS; Candotti F
J Allergy Clin Immunol; 2012 Mar; 129(3):762-769.e1. PubMed ID: 22153773
[TBL] [Abstract][Full Text] [Related]
31. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
Bianchini L; Maire G; Pedeutour F;
Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
[TBL] [Abstract][Full Text] [Related]
32. Dermatofibrosarcoma protuberans with platelet-derived growth factor-D rearrangement; two cases with morphologically distinct presentations.
Campbell K; Bridge JA; DiMaio D; Wilson J; Shalin SC; Gardner JM
J Cutan Pathol; 2022 Mar; 49(3):274-277. PubMed ID: 34628665
[TBL] [Abstract][Full Text] [Related]
33. COL1A1::PDGFB fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract][Full Text] [Related]
34. Perspectives of Patients With Dermatofibrosarcoma Protuberans on Diagnostic Delays, Surgical Outcomes, and Nonprotuberance.
David MP; Funderburg A; Selig JP; Brown R; Caliskan PM; Cove L; Dicker G; Hoffman L; Horne T; Gardner JM
JAMA Netw Open; 2019 Aug; 2(8):e1910413. PubMed ID: 31469398
[TBL] [Abstract][Full Text] [Related]
35. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. Molecular abnormalities of the p53 pathway in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.
Hisaoka M; Okamoto S; Morimitsu Y; Tsuji S; Hashimoto H
Virchows Arch; 1998 Oct; 433(4):323-9. PubMed ID: 9808434
[TBL] [Abstract][Full Text] [Related]
36. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
[TBL] [Abstract][Full Text] [Related]
37. Dermatofibrosarcoma protuberans, version 1.2014.
Bichakjian CK; Olencki T; Alam M; Andersen JS; Berg D; Bowen GM; Cheney RT; Daniels GA; Glass LF; Grekin RC; Grossman K; Ho AL; Lewis KD; Lydiatt DD; Morrison WH; Nehal KS; Nelson KC; Nghiem P; Perlis CS; Shaha AR; Thorstad WL; Tuli M; Urist MM; Wang TS; Werchniak AE; Wong SL; Zic JA; McMillian N; Hoffman K; Ho M
J Natl Compr Canc Netw; 2014 Jun; 12(6):863-8. PubMed ID: 24925197
[TBL] [Abstract][Full Text] [Related]
38. Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.
Rutkowski P; Van Glabbeke M; Rankin CJ; Ruka W; Rubin BP; Debiec-Rychter M; Lazar A; Gelderblom H; Sciot R; Lopez-Terrada D; Hohenberger P; van Oosterom AT; Schuetze SM; ;
J Clin Oncol; 2010 Apr; 28(10):1772-9. PubMed ID: 20194851
[TBL] [Abstract][Full Text] [Related]
39. Imatinib Treatment for Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans: A Systematic Review.
Navarrete-Dechent C; Mori S; Barker CA; Dickson MA; Nehal KS
JAMA Dermatol; 2019 Mar; 155(3):361-369. PubMed ID: 30601909
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
